Biodexa Pharmaceuticals PLC Files 6-K
Ticker: BDRX · Form: 6-K · Filed: Jun 13, 2025 · CIK: 1643918
| Field | Detail |
|---|---|
| Company | Biodexa Pharmaceuticals PLC (BDRX) |
| Form Type | 6-K |
| Filed Date | Jun 13, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 6-K, shareholder-meeting, foreign-private-issuer
TL;DR
Biodexa Pharma filed a 6-K on June 13th about a June 11th shareholder meeting. Nothing major disclosed yet.
AI Summary
Biodexa Pharmaceuticals PLC filed a Form 6-K on June 13, 2025, reporting on a general meeting of shareholders held on June 11, 2025. The filing indicates that the company previously disclosed information regarding this meeting. Biodexa Pharmaceuticals PLC is located at 1 Caspian Point, Caspian Way, Cardiff, CF10 4DQ, United Kingdom.
Why It Matters
This filing provides an update on company activities and shareholder decisions, which can be important for investors tracking the company's governance and strategic direction.
Risk Assessment
Risk Level: low — The filing is a routine report of foreign private issuer and does not contain significant new financial or operational information.
Key Players & Entities
- Biodexa Pharmaceuticals PLC (company) — Registrant
- June 11, 2025 (date) — Date of shareholder meeting
- June 13, 2025 (date) — Filing date
- 1 Caspian Point, Caspian Way, Cardiff, CF10 4DQ, United Kingdom (location) — Company address
FAQ
What was the purpose of the shareholder meeting on June 11, 2025?
The filing states that the meeting was previously disclosed, but the specific purpose is not detailed within this 6-K document.
What specific information was disclosed at the shareholder meeting?
This Form 6-K filing indicates that information was previously disclosed regarding the meeting, but it does not provide the details of what was disclosed.
Is Biodexa Pharmaceuticals PLC a US-based company?
No, Biodexa Pharmaceuticals PLC is a foreign private issuer, as indicated by the Form 6-K filing and its UK address.
What is the SIC code for Biodexa Pharmaceuticals PLC?
The Standard Industrial Classification (SIC) code for Biodexa Pharmaceuticals PLC is 2834, which corresponds to Pharmaceutical Preparations.
When was the company formerly known as Midatech Pharma Plc?
The company was formerly known as Midatech Pharma Plc, with a date of name change on June 2, 2015.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 13, 2025 regarding Biodexa Pharmaceuticals Plc (BDRX).